Alzheimer's disease and related dementias in a diverse cohort of Asian Americans
Alzheimer's disease and related dementias in a diverse cohort of Asian Americans
批准号:
10407959
负责人:
Elizabeth Rose Mayeda
金额:
$49.87万
依托单位国家:
美国
项目类别:
财政年份:
2019
资助国家:
美国
项目状态:
未结题
起止时间:
2019-09-01 至 2025-04-30
关键词:
AddressAgeAlzheimer&aposs disease related dementiaAmericanAsianAsian AmericansAsian ancestryChineseChinese AmericanDataDiabetes MellitusDiagnosisDiscriminationEducationEducational BackgroundEthnic groupEuropeanFilipinoFilipino AmericanGenerationsGeneticGenotypeGoalsHealthHeterogeneityHypertensionImmigrantIncidenceIncomeIndividualJapaneseJapanese AmericanMeasuresMedical RecordsNeighborhoodsPatternPersonsPhilippinesPopulation HeterogeneityPublic HealthRecording of previous eventsResearchResourcesRiskRisk FactorsRoleSamplingSpanish AmericansStrokeSurveysVariantapolipoprotein E-4cardiometabolismcohortdementia riskdiscountingdisparity reductionexperiencehealth planmemberneighborhood disadvantagepreventprotective factorsracial and ethnicsocialsocial factors
中文摘要
项目总结
英文摘要
PROJECT SUMMARY
Over one in four Asian Americans who survive to age 65 can expect to be diagnosed with Alzheimer’s disease
and related dementias (ADRD), yet Asian Americans are under-represented in ADRD research, and
heterogeneity in risk across Asian ethnic groups is poorly understood. In the most comprehensive study to
date, our research team discovered marked differences in ADRD incidence between Asian American ethnic
groups (ADRD incidence was 27% higher in Filipino Americans than Chinese Americans). Despite the major
differences in ADRD risk between groups, all Asian ethnic groups had lower ADRD risk than non-Latino whites
(25% higher rate in non-Latino whites than Asian Americans). These findings have major public health
implications: reducing ADRD rates in all racial/ethnic groups to rates observed in Asian Americans would
prevent >190,000 ADRD cases annually in the U.S. Yet it is unknown why Asian Americans have lowered
ADRD incidence or why Asian ethnic groups differ. Disentangling these puzzles will inform our understanding
of the determinants of ADRD in people of all racial/ethnic backgrounds and help address the major gap in
research on drivers of health in Asian Americans, the fastest growing racial/ethnic group in the U.S. The overall
objective of this application is to examine how social factors, cardiometabolic health, and genetic factors
contribute to lower ADRD risk in Asian Americans and differences in risk between Asian ethnic groups (Filipino
Americans, Chinese Americans, and Japanese Americans). The rationale for the proposed research is that
delineating risk and protective factors for ADRD in Asian Americans will unlock why Asian Americans have
lower ADRD risk than other racial/ethnic groups and identify potential strategies to prevent ADRD and reduce
ADRD disparities. We have assembled survey data, neighborhood information, and 24 years of medical
records on ~12,000 Filipino, Japanese, and Chinese American Kaiser health plan members that will be
matched 1:3 to a sample of non-Latino whites. Further, approximately 25% of the sample has genotype data
available. This is the largest, most diverse longitudinal sample of Asian Americans with a rich set of biomedical
and social data relevant to ADRD available. Our Specific Aims are: 1) evaluate the role of social factors
(generational status, educational attainment, income, neighborhood disadvantage metrics, neighborhood
ethnic enclaves) on ADRD risk in Asian Americans; 2) evaluate the role of cardiometabolic health (diabetes,
hypertension, stroke) on ADRD risk in Asian Americans; 3) determine whether genetic ancestry and APOE
genotype influence variation in ADRD incidence observed in Asian Americans. Examining the roles of social,
cardiometabolic, and genetic factors on ADRD risk in a large, diverse cohort of Asian Americans and whites
will provide valuable information to prevent ADRD in people of all racial/ethnic backgrounds and reduce ADRD
disparities.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Optimizing generalizability of biomarker studies for Alzheimer’s disease and related dementias with epidemiologic tools
-
批准号:10359225
-
项目类别:
-
资助金额:$58.25万
-
财政年份:2021
-
负责人:Elizabeth Rose Mayeda
-
依托单位:
Alzheimer's disease and related dementias in a diverse cohort of Asian Americans
-
批准号:10000819
-
项目类别:
-
资助金额:$46.86万
-
财政年份:2019
-
负责人:Elizabeth Rose Mayeda
-
依托单位:
Racial Disparities in Alzheimer's Disease and Related Dementias: The Role of Blood Pressure Throughout Adulthood
-
批准号:9164027
-
项目类别:
-
资助金额:$12.63万
-
财政年份:2016
-
负责人:Elizabeth Rose Mayeda
-
依托单位:
Racial Disparities in Alzheimer's Disease and Related Dementias: The Role of Blood Pressure Throughout Adulthood
-
批准号:9899176
-
项目类别:
-
资助金额:$22.4万
-
财政年份:2016
-
负责人:Elizabeth Rose Mayeda
-
依托单位:
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位:
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
-
批准号:81973577
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:辛贵忠
-
依托单位:
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
-
批准号:81602908
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2016
-
负责人:刘括
-
依托单位: